Loxo Oncology, Inc. EBITDA 2014-2018 | LOXO
Loxo Oncology, Inc. ebitda from 2014 to 2018. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Loxo Oncology, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2017 | $-152 |
| 2016 | $-73 |
| 2015 | $-36 |
| 2014 | $-21 |
| 2013 | $-10 |
| Loxo Oncology, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2018-09-30 | $-31 |
| 2018-06-30 | $-15 |
| 2018-03-31 | $-6 |
| 2017-12-31 | $-43 |
| 2017-09-30 | $-74 |
| 2017-06-30 | $-31 |
| 2017-03-31 | $-25 |
| 2016-12-31 | $-27 |
| 2016-09-30 | $-18 |
| 2016-06-30 | $-16 |
| 2016-03-31 | $-12 |
| 2015-12-31 | $-13 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-8 |
| 2015-03-31 | $-6 |
| 2014-12-31 | $-7 |
| 2014-09-30 | $-7 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-3 |
| 2013-09-30 | $-8 |
